| ||||
| ||||
|
 Keeping you updated on 2010 Data Changes. 03/01/10 CSv2 PART I Available for Download!
Part I, Section 1: General Rules [125 pgs] & Part I, Section 2: Lab Tests, Tumor Markers, and Site- Specific Factor Notes [130 pgs] PDFs. 02/18/10 Order past Webinars! Learn more @ Archived Webinars 02/04/10 Order past Webinars! Learn more @ Archived Webinars 01/14/10 The new version incorporates significant changes to collaborative staging that are effective for cases diagnosed on or after January 1, 2010, and are based on the American Joint Committee on Cancer's (AJCC) Cancer Staging Manual, 7th edition. Available at http://cancerstaging.org/cstage/index.html, CSv2 contains software programs and tools, general instructions and implementation guidelines, site-specific codes and coding instructions for the new variables, and standard-setter requirements. Cases diagnosed in 2010 must be coded using the revised version. Commission on Cancer (CoC)-accredited programs should install software updates before abstracting 2010 diagnoses. The CSv2 software will include new staging algorithms and will utilize the data elements as defined in the North American Association of Central Cancer Registries (NAACCR) Inc.?s Record Layout Standards, Volume II, Version 12. Registry software systems must incorporate the new CSv2 software. In addition, current registry data will need to be converted to the new CSv2 and NAACCR version 12 standards prior to using CSv2. Specifications for the data conversion will be available on the CS Web page. The Centers for Disease Control and Prevention will provide a program for the conversion of the staging data elements. If abstracting of 2010 cases begins before the software is updated, it will be necessary to review those cases after the update to code the new items and ensure that converted items have specific codes assigned. Electronic conversion of Class of Case and Race items may result in broader categories than the items require for 2010 cases. Cases diagnosed prior to 2010 may be coded using the new layout, but it is not necessary to code the items with a 2010 implementation date. To ensure correct conversion and derivation of CS data, all records in the registry database with staging information diagnosed from 1/1/2004 through the date of implementation must be processed through the CSv2 conversion algorithm. AJCC 6 stage and SS1977 and SS2000 will be re-derived on all cases where sufficient information is available. Registries are urged to identify all edits developed for use with CSv1 on the fields they collect and re-edit all cases before implementation of CSv2. CSv1 edits were added to the standard NAACCR metafile at intervals from 2004 through mid-2009; all CSv1 cases in the registry database may not have passed through all available CS edits. Users can expect fewer conversion problems with edited data. Once CSv2 is installed, it will be the only CS version used for all cases diagnosed from the year 2004 to the present, regardless of diagnosis year. The CSv2 algorithm for AJCC 6 and 7 will be applied to cases as described below: The CS Implementation Guide, CSv2 User Documentation, and other tools will provide detailed information to ensure a smooth transition from CSv1 to CSv2. These documents are also available on the CS Web page. Recommendations and Requirements for Implementation of CS Version 02.00.01 Vendor and general questions regarding the CS release can be submitted to CSv2@facs.org. All technical and coding questions should be submitted to the Inquiry and Response (I&R) System. Note: The CS Web pages have been redesigned for CSv2, and any bookmarks for pages within the Web site may need to be reset. 01/07/10 Order past Webinars! Learn more @ Archived Webinars 12/09/09 SEER announced the Hematopoietic Database (DB) is now available on the SEER website. The Hematopoietic and Lymphoid Neoplasm Case Reportability and Coding Manual is embedded in the Hematopoietic DB. The Manual can be accessed from the first screen of the Hematopoietic DB by clicking on the Hemato Manual button located on the lower-right of the screen. A total of 13 hematopoietic educational presentations will be available on the SEER website. There is no charge for the Hematopoietic DB, the manual, or any of the presentations. Download Hematopoietic DB with the embedded Manual. Main contact: NCISEERQI@mail.nih.gov. 12/08/09 NAACCR's 2010 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 12, effective with cases diagnosed on or after January 1, 2010) have been released. They have been completed to the best of the ability of the work group. At the time the guidelines were released the materials for CSV2 and Hematopoietic MP/H Rules were not finalized; therefore, more detailed information could not be incorporated in to the guidelines. As updated information is received it will be shared with the NAACCR membership through the NAACCR listserv. Access NAACCR's 2010 Implementation Guidelines and Recommendations (PDF). 12/07/09 CSv2 Speakers Bureau members were trained to deliver presentations and case exercises that address the following sites included in version two of the Collaborative Stage Data Collection System. View Speakers
Bureau lists. 12/03/09 Pre-Order the Archived Webinars 11/23/09 Go to the Case Data Collection Site. (account required) 11/05/09 Pre-Order the Archived Webinars 10/22/09 Pre-Order the Archived Webinars 10/14/09 Considered the gold standard in cancer staging, the AJCC Cancer Staging Manual brings together the appropriate and evidence-based criteria for the staging of cancer for 52 anatomic primary sites, which includes the rational and rules for staging; the background explanation of the changes between the sixth and seventh editions; the definitions of tumor, lymph node involvement, and metastasis; stage groupings; and histologic grade. “The AJCC believes this newly released Edition of the AJCC Cancer Staging Manualwill enhance the utility of the TNM* staging to patients and clinicians,” said Stephen Edge, MD, FACS, the publication’s editor. “This seventh edition is also a springboard to the exciting future of personalized cancer care using data to more specifically define prognosis and the potential for benefit from specific therapies,” Dr. Edge said. Published by Springer, the manual, handbook, and atlas are all prepared by the AJCC in collaboration with its member organizations, including the American Cancer Society, which provided primary funding for the development. These organizations work with the AJCC in the promotion of staging at the time of diagnosis in order to achieve better patient outcomes. 10/08/09 Pre-Order the Archived Webinars 10/2/2009
09/24/09 Pre-Order the Archived Webinars 09/17/09
09/3/09 Pre-Order the Archived Webinars 09/2/09 TOPIC: Session Information: 2010 Cancer Data Collection Updates: Standards Volume II, Version 12. 09/01/09 Take the Online Survey. Survey deadline = 9/15/09 08/29/09 "Webinar series will provide educational opportunities that are accessible and cost appropriate...NCRA has been involved in understanding these changes to be fully prepared to ascertain and deliver on the educational needs of the members and greater cancer registry community." 8/15/2009
08/05/09 07/31/09 07/16/09 06/10/09 "Six activities need to be on every registrar's 2010 readiness action plan: 06/01/09 05/20/09 "NAACCR and standard setters in cancer surveillance chose to implement major changes every 3 years to hopefully lighten the load on registrars and give them time to get ready for the new guidelines. Some in the cancer registry field have expressed concerns about the bulk of the changes coming in 2010..." 4/01/2009 The latest revision of Collaborative Staging (CS) has provided an opportunity for many standards-setters, vendors, and other interested organizations to work together towards a new version of the Collaborative Staging that is compatible with the AJCC Cancer Staging Manual, 7th Edition. The AJCC manual will be published in summer 2009 and be effective with January 1, 2010, cancer cases. The Collaborative Staging system is a joint effort between all standards-setting agencies and organizations involved in cancer surveillance in North America. These include AJCC, CoC, CDC/NPCR, NCI/SEER, NCRA, NAACCR, and Canadian Council of Cancer Registries. Several teams are involved in creating the changes necessary for CSv2—read about them in detail below... Read full article...pages 1 & 4. 02/01/09 12/31/08 "Advances in cancer medicine necessitate changes in how cancer data is collected. Some of these changes include the study of new biomarkers or existing tests that have new prognostic meaning. Diagnostic workup will begin to include the new markers that guide treatment decisions resulting in prognostic changes. These biomarkers and other significant prognostic information will be incorporated into the Site-Specific Factors (SSFs) of Collaborative Staging Version 2 (CSv2). Cancer Registrars play an important role in collecting and reporting data vital to providing quality care, understanding incidence and mortality, and patterns of care and outcomes." Read full article...pages 16-17. 12/01/08 "Changes to The North American Association of Central Cancer Registries (NAACCR) record layout that will affect coding and abstracting for the year 2010 are being developed. Several years ago, national standard setters for cancer surveillance agreed major changes needed to be curtailed to once every 3 years. This was to allow for all the difficulties in making programmatic changes, education to learn new standards, labor costs, etc. We are now preparing for our first 3-year cycle when major changes can happen. Consequently, we have 3 major changes happening at one time."
Tips on news &/or resources to be shared? Contact NCRA's Advocacy & Technical Practice Directors.
|
